PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
8,50 USD
0,00%
(0,00) 1d
12 d’oct., 10:22:09 GMT-4 · USD
search
Tots els símbols
| Símbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadístiques principals per a PTKFY...
Capitalització borsària
36,98 B
Volum mitjà
1,96 k
Volum
69,00
Alt 52 setmanes
16,36 USD
Baix 52 setmanes
7,63 USD
Versió beta
0,09
Accions en circulació
234,07 M
Nombre d'empleats
13 k
Capitalització borsària
36,98 B
Volum mitjà
1,96 k
Volum
69,00
Alt 52 setmanes
16,36 USD
Baix 52 setmanes
7,63 USD
Versió beta
0,09
Accions en circulació
234,07 M
Nombre d'empleats
13 k
Notícies
De fonts web i partners de notícies
ad-hoc-news.de
·
fa 23 hores
Kalbe Farma announced IDR 500 billion buyback of Kalbe Farma stock
Perfil
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Sobre PT Kalbe Farma Unsponsored Indonesia ADR